Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Status epilepticus in adults
John P. Betjemann, Daniel H. Lowenstein
The Lancet Neurology (2015) Vol. 14, Iss. 6, pp. 615-624
Closed Access | Times Cited: 441

Showing 1-25 of 441 citing articles:

Recording, analysis, and interpretation of spreading depolarizations in neurointensive care: Review and recommendations of the COSBID research group
Jens P. Dreier, Martin Fabricius, Cenk Ayata, et al.
Journal of Cerebral Blood Flow & Metabolism (2016) Vol. 37, Iss. 5, pp. 1595-1625
Open Access | Times Cited: 310
Thermoregulatory disorders and illness related to heat and cold stress
William P. Cheshire
Autonomic Neuroscience (2016) Vol. 196, pp. 91-104
Open Access | Times Cited: 289
25 years of advances in the definition, classification and treatment of status epilepticus
Eugen Trinka, Reetta Kälviäinen
Seizure (2016) Vol. 44, pp. 65-73
Closed Access | Times Cited: 203
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
James M. Chamberlain, Jaideep Kapur, Shlomo Shinnar, et al.
The Lancet (2020) Vol. 395, Iss. 10231, pp. 1217-1224
Open Access | Times Cited: 199
Management of Status Epilepticus, Refractory Status Epilepticus, and Super-refractory Status Epilepticus
Eugen Trinka, Markus Leitinger
CONTINUUM Lifelong Learning in Neurology (2022) Vol. 28, Iss. 2, pp. 559-602
Closed Access | Times Cited: 75
Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability
Ricardo Kienitz, Lara Kay, Isabelle Beuchat, et al.
CNS Drugs (2022) Vol. 36, Iss. 9, pp. 951-975
Open Access | Times Cited: 73
Acute encephalitis in immunocompetent adults
Arun Venkatesan, Benedict Michael, John C. Probasco, et al.
The Lancet (2019) Vol. 393, Iss. 10172, pp. 702-716
Closed Access | Times Cited: 141
Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients
Chloé E. Hill, Leah J. Blank, Dylan Thibault, et al.
Neurology (2018) Vol. 92, Iss. 1
Open Access | Times Cited: 130
The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data
Adam Strzelczyk, Claudia Griebel, Wolfram Lux, et al.
Frontiers in Neurology (2017) Vol. 8
Open Access | Times Cited: 125
Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial
Vincent Navarro, C. Dagron, Caroline Elie, et al.
The Lancet Neurology (2015) Vol. 15, Iss. 1, pp. 47-55
Closed Access | Times Cited: 124
Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial
Abhishek G. Sathe, Ellen Underwood, Lisa D. Coles, et al.
Epilepsia (2021) Vol. 62, Iss. 3, pp. 795-806
Open Access | Times Cited: 65
Why won’t it stop? The dynamics of benzodiazepine resistance in status epilepticus
Richard J. Burman, Richard Rosch, Jo M. Wilmshurst, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 428-441
Closed Access | Times Cited: 63
Lactate Is Answerable for Brain Function and Treating Brain Diseases: Energy Substrates and Signal Molecule
Ming Cai, Hongbiao Wang, Haihan Song, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 41
Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
Akanksha Onkar, Fatima Khan, Anshika Goenka, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6709-6742
Closed Access | Times Cited: 10
ATPergic signalling during seizures and epilepsy
Tobías Engel, Mariana Alves, Caroline Sheedy, et al.
Neuropharmacology (2015) Vol. 104, pp. 140-153
Closed Access | Times Cited: 88
Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score
Qiong Gao, Tang-Peng Ou-Yang, Xiaolong Sun, et al.
Critical Care (2016) Vol. 20, Iss. 1
Open Access | Times Cited: 86
Costs and cost‐driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany
Lena‐Marie Kortland, Anne Alfter, Oliver Bähr, et al.
Epilepsia (2016) Vol. 57, Iss. 12, pp. 2056-2066
Open Access | Times Cited: 80
Timing is everything: Where status epilepticus treatment fails
Chloé E. Hill, Alomi O. Parikh, Colin A. Ellis, et al.
Annals of Neurology (2017) Vol. 82, Iss. 2, pp. 155-165
Open Access | Times Cited: 79
Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals
Adam Strzelczyk, Isabel Steinig, Laurent M. Willems, et al.
Epilepsy & Behavior (2017) Vol. 70, pp. 177-181
Closed Access | Times Cited: 73
Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model
Satoru M. Sato, Catherine S. Woolley
eLife (2016) Vol. 5
Open Access | Times Cited: 72
Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults
Martin Holtkamp
Drugs (2018) Vol. 78, Iss. 3, pp. 307-326
Closed Access | Times Cited: 68
Treatment of Established Status Epilepticus
Jessica Falco-Walter, Thomas P. Bleck
Journal of Clinical Medicine (2016) Vol. 5, Iss. 5, pp. 49-49
Open Access | Times Cited: 66
The Neuroprotective Effect of Astaxanthin on Pilocarpine-Induced Status Epilepticus in Rats
Xiaolin Deng, Ming Wang, Sihui Hu, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 65
Gap Analysis Regarding Prognostication in Neurocritical Care: A Joint Statement from the German Neurocritical Care Society and the Neurocritical Care Society
Katja E. Wartenberg, David Y. Hwang, Karl Georg Hæusler, et al.
Neurocritical Care (2019) Vol. 31, Iss. 2, pp. 231-244
Open Access | Times Cited: 64
Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery
Mihika Shringarpure, Sankalp Gharat, Munira Momin, et al.
Expert Opinion on Drug Delivery (2020) Vol. 18, Iss. 2, pp. 169-185
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top